Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Mopidamol (RA 233) is a phosphodiesterase inhibitor, a dipyridamole derivative, with anticancer activity that prevents retinal vascular defects in experimental diabetes.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 380.00 | |
5 mg | In stock | $ 889.00 | |
10 mg | In stock | $ 1,230.00 | |
25 mg | In stock | $ 1,830.00 | |
50 mg | In stock | $ 2,180.00 | |
100 mg | In stock | $ 2,800.00 |
Description | Mopidamol (RA 233) is a phosphodiesterase inhibitor, a dipyridamole derivative, with anticancer activity that prevents retinal vascular defects in experimental diabetes. |
Targets&IC50 | Lipid peroxidation:89 μmol/L |
Synonyms | RA233, RA 233, RA-233, Rapenton, OLX 102 |
Molecular Weight | 421.49 |
Formula | C19H31N7O4 |
CAS No. | 13665-88-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (118.63 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Mopidamol 13665-88-8 Metabolism PDE RA233 RA 233 OLX-102 OLX102 RA-233 Rapenton OLX 102 inhibitor inhibit